Skip to main content
. 2021 Feb 4;11:614488. doi: 10.3389/fimmu.2020.614488

Figure 1.

Figure 1

Cumulative incidence of relapse among all patients (A), the myeloid cohort (B), and the lymphoid cohort (C), based on the variation (D, decreased; U, unchanged; I, increased) in iKIR-HLA C pair post-transplantation.